Study summary

Starting two kidney drugs together cut kidney protein loss by about 30% more

CONFIDENCE trial (finerenone plus empagliflozin) · 784 people with results, phase 2 · Published June 2025, New England Journal of Medicine

29%greater drop in urine albumin than finerenone alone

What was tested

Finerenone and empagliflozin started together, against either drug alone, in type 2 diabetes with chronic kidney disease and protein in the urine.

What they found

What it means

Supports starting both drugs at once rather than one at a time.

N Engl J Med, via PubMed ↗ Trial record NCT05254002 ↗ ← Back to the outlook
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.